Clinical Trials Logo

Filter by:
NCT ID: NCT04209608 Completed - Clinical trials for Anesthesia Complication

Observational Study on Respiratory Impact of High-frequency Jet Ventilation (JVHF) in Interventional Radiology (RI)

Pulmojet
Start date: March 12, 2020
Phase:
Study type: Observational

Jet ventilation is used in interventional radiology to reduce respiratory movement and facilitate tumor destruction. The purpose of this study is to describe the respiratory impact of this technique

NCT ID: NCT04209582 Completed - Ankle Injuries Clinical Trials

Transcutaneous Oxygen Pressure of the Injured Ankle as Predictor of Postoperative Cutaneous Pain

TAC
Start date: February 3, 2020
Phase:
Study type: Observational

This monocentric prospective observational pilot study aims to investigate if the measurement of TcPO2 can be used as a predictor of postoperative cutaneous pain in patients with ankle surgery.

NCT ID: NCT04209426 Completed - Clinical trials for Primary Total Hip Arthroplasty

Retrospective Observational Cohort Study of SYMBOL CUP DM 2

SYMCOR-2
Start date: March 18, 2015
Phase:
Study type: Observational

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty with a SYMBOL CUP DMR HA or a SYMBOL CUP DM CEM hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of those two implants at two-year follow-up.

NCT ID: NCT04209374 Completed - Clinical trials for Primary Total Hip Arthroplasty

Retrospective Observational Cohort Study of SYMBOL CUP DM 1

SYMCOR-1
Start date: July 3, 2014
Phase:
Study type: Observational

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent primary total hip arthroplasty with a SYMBOL CUP DM HA hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of that implant at two-year follow-up.

NCT ID: NCT04209114 Completed - Bladder Cancer Clinical Trials

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Start date: February 5, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to see if treatment with nivolumab plus bempegaldesleukin or nivolumab alone, before and after surgery to remove the bladder, is more effective than surgery alone in participants with high-risk urothelial cancer, including muscle-invasive bladder cancer who are not able to receive cisplatin chemotherapy.

NCT ID: NCT04209101 Completed - Clinical trials for Psychoactive Substances Consumption

Medical Students and Psychoactive Substances Use

NC
Start date: January 1, 2017
Phase:
Study type: Observational

Medical students are heavy users of psychoactive substances, and even if levels of use vary depending on the universities, the average levels are higher than most other students. In France, however, the use of licit or illicit substance has not been precisely described in medical students. The aim of this study was therefore to define the different modes of consumption of medical students. Methods: This study was a cross-sectional survey in medical students from the University of Montpellier, and the investigators performed a cluster analysis of data. Both medical students and residents were included. Socio-demographic, medico-psychological and addictological data were collected.

NCT ID: NCT04206826 Completed - Xerostomia Clinical Trials

Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study

PREDELFI
Start date: June 25, 2020
Phase: N/A
Study type: Interventional

Xerostomia affects at least a quarter of the population. This prevalence is increased in postmenopausal women and people over 65 years of age. Associated with age are systemic diseases such as Sjögren's Syndrome, diabetes, Parkinson's disease or cancer. It handicaps the patient in his social life, but also in terms of his well-being by the consequences it generates in the oral cavity. This dryness may be the consequence of taking certain medications, head and neck radiotherapy, but also being a symptom of an underlying pathology whose screening will allow early treatment and avoid complications. Today, no single therapeutic solution is enough and patients are waiting for new therapeutic innovations in this area. This study proposes to evaluate the tolerance of an adhesive film containing prebiotics by comparing it to a placebo control film.

NCT ID: NCT04206774 Completed - Syncope Clinical Trials

BIO|STREAM.ICM France

Start date: March 13, 2020
Phase:
Study type: Observational

The main objective of the BIO│STREAM.ICM France submodule is to provide clinical evidence from patients in France on safety and efficacy of the BIOMONITOR system

NCT ID: NCT04206605 Completed - Angioedema Clinical Trials

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Start date: May 4, 2020
Phase: Phase 3
Study type: Interventional

The main aim of this study is to check if repeated subcutaneous (SC) injections of lanadelumab can prevent angioedema attacks in teenagers and adults with non-histaminergic angioedema with normal C1-INH. Another aim is to check if they tolerate the repeated SC injections. Participants will receive a SC injection of lanadelumab every two weeks for 26 weeks. The first two doses of lanadelumab will be given at the study clinic. Once a participant (and/or parent/caregiver) has been appropriately trained, lanadelumab can be self-injected. Visits to the study clinic are planned for the first, third and fourth week and then every 4 weeks.

NCT ID: NCT04206371 Completed - Clinical trials for Implantable Cardioverter-Defibrillators

Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement

T-DEF
Start date: February 3, 2020
Phase: N/A
Study type: Interventional

This study will evaluate safety and clinical outcomes of a systematic defibrillation threshold testing in patient with indication for defibrillator replacement.